ISIN | CH0368190739 |
---|---|
Valor Number | 36819073 |
Bloomberg Global ID | CHSRI SW |
Fund Name | UBS ETF (CH) - UBS MSCI Switzerland IMI Socially Responsible ETF CHF dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Asset Allocation |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | n/a |
Peculiarities |
Current Price * | 18.73 CHF | 18.07.2025 |
---|---|---|
Previous Price * | 18.65 CHF | 17.07.2025 |
52 Week High * | 18.90 CHF | 06.06.2025 |
52 Week Low * | 15.97 CHF | 09.04.2025 |
NAV * | 18.73 CHF | 18.07.2025 |
Issue Price * | 18.73 CHF | 18.07.2025 |
Redemption Price * | 18.73 CHF | 18.07.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 525,879,185 | |
Unit/Share Assets *** | 269,000,780 | |
Trading Information SIX |
YTD Performance | +7.93% |
31.12.2024 - 18.07.2025
31.12.2024 18.07.2025 |
---|---|---|
1 month | +1.76% |
18.06.2025 - 18.07.2025
18.06.2025 18.07.2025 |
3 months | +8.52% |
22.04.2025 - 18.07.2025
22.04.2025 18.07.2025 |
6 months | +4.73% |
20.01.2025 - 18.07.2025
20.01.2025 18.07.2025 |
1 year | +5.44% |
18.07.2024 - 18.07.2025
18.07.2024 18.07.2025 |
2 years | +21.08% |
18.07.2023 - 18.07.2025
18.07.2023 18.07.2025 |
3 years | +24.53% |
18.07.2022 - 18.07.2025
18.07.2022 18.07.2025 |
5 years | +38.83% |
20.07.2020 - 18.07.2025
20.07.2020 18.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 10.55% | |
---|---|---|
Lonza Group Ltd | 10.25% | |
UBS Group AG Registered Shares | 10.14% | |
ABB Ltd | 10.12% | |
Roche Holding AG | 10.04% | |
Sika AG | 9.84% | |
Alcon Inc | 9.70% | |
Zurich Insurance Group AG | 9.68% | |
Givaudan SA | 9.53% | |
Swiss Re AG | 9.45% | |
Last data update | 30.06.2025 |
TER | 0.28% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.28% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |